4. Discussion
DYSLIPIDEMIA
This randomized controlled trial, conducted over a period of four months with adults aged 30–70 years old suffering from dyslipidemia, indicated that the consumption of NMSs led to a favorable improvement in lipid levels, suggesting a potential mechanism by which NMSs may reduce cardiovascular risk. However, no significant effect of NMSs on the CIMT was observed after the 120-day intervention. 